NFKB1 and melanoma: One study focused on the effect of combined BET and MCL 1 inhibitors and determined that this combination induces apoptosis in melanoma cells by downregulating NF-κB-regulated anti-apoptotic proteins, including BCL2A1 and XIAP, while upregulating pro-apoptotic proteins, such as BIM and NOXA.